Drug profile · INN
ustekinumab-aekn
SELARSDI
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
ustekinumab-aekn (SELARSDI) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN ustekinumab-aekn
Brand SELARSDI
Route INJECTION
Formulation INJECTABLE
Frequently asked questions
What is ustekinumab-aekn?
ustekinumab-aekn (SELARSDI) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for ustekinumab-aekn?
SELARSDI is a marketed brand name for ustekinumab-aekn. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of ustekinumab-aekn?
ustekinumab-aekn has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.